Contact Us


The Hospital For Sick Children 

555 University Avenue

Toronto, Ontario


M5G 1X8

To learn more about the NEOPICS team and how to get in touch with them click here.

​Inflammatory Bowel Disease (IBD) is a chronic condition that causes the gastrointestinal tract to become inflamed (red, sore, or swollen). Two main types of IBD are Crohn’s disease and Ulcerative Colitis. Painful symptoms are often managed with lifelong medications, therapies, or even surgery to remove or repair diseased areas.

​IBD can occur at any age, but patients who develop it as young children have a distinct form regarding disease location, disease extension over time, and a disease that is often challenging to treat. Growth may be impaired, and school and social development can be interrupted by frequent disease flare-ups and hospitalizations. While the causes of IBD are complex, genetics are generally considered to play a more important role in these very young children.

These differences and the role of genetics are especially seen at the earliest ages:
-Diagnosed under age 10: Early Onset IBD
-Diagnosed under age 6: Very Early Onset Inflammatory Bowel Disease (VEO-IBD)
​-Diagnosed under age 1: Infantile IBD

​The interNational Early Onset Paediatric IBD Cohort Study (NEOPICS) is a SickKids’ based initiative that brings together international paediatric gastroenterologists and scientists from academic centers around the world to work together. Our goals are to identify and investigate the causes, and develop new treatments and cures for these young children and infants with IBD. We believe children with IBD deserve to be healthy, happy, and live a full life alongside their peers.

SickKids IBD Centre 

To learn more about the SickKids Inflammatory Bowel Disease Centre, including announcements and  upcoming events click the link below.

SickKids IBD Centre

If you would like to donate to The Hospital for Sick Children's Inflammatory Bowel Disease Centre please follow the link below.

Donate to the IBD Centre

Learn More

Learn more about the NEOPICS study and how it is improving the treatment of Very Early Onset Inflammatory Bowel Disease.

  • Our Logo
  • The VEOIBD Roadmap
  • NEOPICS in the News